Pharmacogenomic considerations in the opioid management of pain
Physicians continue to struggle with the clinical management of pain, in part because of the large interindividual variability in the efficacy, occurrence of side effects and undesired severe adverse drug reactions from the prescribed analgesics. Pharmacogenomics, the study of how an individual'...
Main Authors: | Jannetto, Paul J, Bratanow, Nancy C |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2010
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092117/ |
Similar Items
-
Pharmacogenomic considerations in opioid analgesia
by: Vuilleumier, Pascal H, et al.
Published: (2012) -
Pharmacogenomics and Opioid Analgesics: Clinical Implications
by: Yiannakopoulou, Eugenia
Published: (2015) -
Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs
by: Xu, Yan, et al.
Published: (2013) -
Considerations in selecting rapid-onset opioids for the management of breakthrough pain
by: Perelman, Michael, et al.
Published: (2013) -
Considerations in selecting rapid-onset opioids for the management of breakthrough pain
by: Smith, Howard S
Published: (2013)